Neuvotion Expands Partnership with Intelligent Product Solutions and Commercializes NeuStim™ Technology for Stroke and Spinal Cord Injury
Neuvotion, an early-stage medical device company, has expanded its partnership with Intelligent Product Solutions (IPS) to commercialize its NeuStim™ technology for stroke and spinal cord injury treatment. Forward Industries, IPS's parent company, has made an undisclosed investment in Neuvotion to accelerate the market launch of NeuStim™.
The company specializes in AI-driven neuromodulation technologies for neurorehabilitation, brain-computer interface, and physical therapy markets. The partnership leverages IPS's medical device design and engineering expertise to bring Neuvotion's solutions to market, aiming to improve patient recovery outcomes.
Neuvotion, una giovane azienda di dispositivi medici, ha ampliato la sua collaborazione con Intelligent Product Solutions (IPS) per commercializzare la sua tecnologia NeuStim™ per il trattamento dell'ictus e delle lesioni del midollo spinale. La società madre di IPS, Forward Industries, ha effettuato un investimento non divulgato in Neuvotion per accelerare il lancio sul mercato di NeuStim™.
L'azienda si specializza in tecnologie di neuromodulazione basate su AI per il mercato della neuroriabilitazione, dell'interfaccia cervello-computer e della fisioterapia. La partnership sfrutta l'expertise di IPS nella progettazione e ingegneria di dispositivi medici per portare sul mercato le soluzioni di Neuvotion, con l'obiettivo di migliorare i risultati della guarigione dei pazienti.
Neuvotion, una empresa de dispositivos médicos en etapa temprana, ha ampliado su asociación con Intelligent Product Solutions (IPS) para comercializar su tecnología NeuStim™ para el tratamiento de accidentes cerebrovasculares y lesiones de la médula espinal. La empresa matriz de IPS, Forward Industries, ha realizado una inversión no divulgada en Neuvotion para acelerar el lanzamiento al mercado de NeuStim™.
La compañía se especializa en tecnologías de neuromodulación impulsadas por AI para los mercados de neurorehabilitación, interfaz cerebro-computadora y terapia física. La asociación aprovecha la experiencia de IPS en diseño e ingeniería de dispositivos médicos para llevar al mercado las soluciones de Neuvotion, con el objetivo de mejorar los resultados de recuperación de los pacientes.
Neuvotion는 초기 단계의 의료기기 회사로, Intelligent Product Solutions (IPS)와의 파트너십을 확대하여 뇌졸중 및 척수 손상 치료를 위한 NeuStim™ 기술을 상업화하고 있습니다. IPS의 모회사인 Forward Industries는 NeuStim™의 시장 출시를 가속화하기 위해 Neuvotion에 비공개 투자를 진행했습니다.
이 회사는 신경 재활, 뇌-컴퓨터 인터페이스 및 물리 치료 시장을 위한 AI 기반의 신경 조절 기술을 전문으로 하고 있습니다. 이번 파트너십은 Neuvotion의 솔루션을 시장에 출시하기 위해 IPS의 의료기기 설계 및 엔지니어링 전문성을 활용하여 환자의 회복 결과를 개선하는 것을 목표로 합니다.
Neuvotion, une entreprise de dispositifs médicaux en phase de démarrage, a élargi son partenariat avec Intelligent Product Solutions (IPS) pour commercialiser sa technologie NeuStim™ destinée au traitement des AVC et des lésions de la moelle épinière. La société mère d'IPS, Forward Industries, a réalisé un investissement non divulgué dans Neuvotion pour accélérer le lancement sur le marché de NeuStim™.
Cette entreprise se spécialise dans les technologies de neuromodulation pilotées par IA pour les marchés de la neuroréhabilitation, des interfaces cerveau-ordinateur et de la thérapie physique. Le partenariat s'appuie sur l'expertise d'IPS en matière de conception et d'ingénierie de dispositifs médicaux pour mettre les solutions de Neuvotion sur le marché, dans le but d'améliorer les résultats de récupération des patients.
Neuvotion, ein Unternehmen für medizinische Geräte in der frühen Phase, hat seine Partnerschaft mit Intelligent Product Solutions (IPS) ausgeweitet, um die NeuStim™ Technologie zur Behandlung von Schlaganfällen und Rückenmarksverletzungen zu kommerzialisieren. Das Mutterunternehmen von IPS, Forward Industries, hat in Neuvotion investiert, um die Markteinführung von NeuStim™ zu beschleunigen.
Das Unternehmen spezialisiert sich auf KI-gesteuerte Neuromodulationstechnologien für die Märkte für Neurorehabilitation, Gehirn-Computer-Schnittstellen und Physiotherapie. Die Partnerschaft nutzt die Design- und Ingenieurexpertise von IPS im Bereich medizinischer Geräte, um die Lösungen von Neuvotion auf den Markt zu bringen und die Genesungsergebnisse der Patienten zu verbessern.
- Strategic partnership secured with established engineering firm IPS
- Received new investment from Forward Industries
- Advancing towards market launch of first product NeuStim™
- Investment amount remains undisclosed
- Product still in pre-market phase
- Early-stage company with no current market presence
Insights
STAMFORD, Conn., Dec. 17, 2024 /PRNewswire/ -- Neuvotion, Inc. is an early-stage medical device company developing AI-driven neuromodulation technologies and products for use in the neurorehabilitation, brain-computer interface (BCI), and physical therapy markets. Today Neuvotion has announced their expanded partnership with Intelligent Product Solutions (IPS), a leading engineering firm located in
"Neuvotion's mission is to develop and bring innovative technologies to the medical market that significantly improve patient outcomes, independence, and overall quality of life," said Chad Bouton, Neuvotion's founder and CEO. "We are extremely excited about the growth of Neuvotion and our expanded partnership with IPS."
"We are proud to help Neuvotion innovate in the rapidly growing neuromodulation and neurorehabilitation markets," said Bob Wild, COO of Intelligent Product Solutions. "NeuStim™ is truly groundbreaking and has the potential to significantly improve recovery outcomes for patients recovering from stroke or spinal cord injury. IPS, with our multidisciplinary team of designers, engineers, and scientists is thrilled to provide medical device design and engineering expertise as Neuvotion brings their life-changing solutions to market."
About Neuvotion, Inc.
Neuvotion is an early-stage medical device company developing solutions for facilitating and restoring movement and sensation to the millions of patients experiencing impairment from stroke, spinal cord injury, and other conditions. Neuvotion's technologies combine high-precision neurostimulation and artificial intelligence to accelerate rehabilitation while making physical and occupational therapy more effective and efficient.
About Intelligent Product Solutions
Intelligent Product Solutions (IPS), a subsidiary of Forward Industries (NASDAQ: FORD), is an award-winning global product design and development company with headquarters in New York. IPS specializes in every stage of product development, from research and discovery to manufacturing, with expertise in systems architecture, industrial and UI/UX design, mechanical engineering, software development, electrical engineering, embedded systems, and manufacturing. To learn more about IPS, visit https://intelligentproduct.solutions or contact info@ips-yes.com.
If you would like more information about this topic, please email info@neuvotion-inc.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/neuvotion-expands-partnership-with-intelligent-product-solutions-and-commercializes-neustim-technology-for-stroke-and-spinal-cord-injury-302332352.html
SOURCE Neuvotion, Inc.
FAQ
What is the purpose of Forward Industries' investment in Neuvotion (FORD)?
What markets will Neuvotion's NeuStim™ technology target?
How will the IPS partnership benefit Neuvotion's product development?
What is the current development stage of Neuvotion's NeuStim™ technology?
